Organovo announces ability to print 3D human liver tissue

April 24, 2013 by Bob Yirka report
The NovoGen Bioprinter fabricating tissue into a 24-well plate.

(Medical Xpress)—Organovo Holdings, Inc., a company that designs and creates functional human tissue has announced at this year's Experimental Biology Conference that it has developed a 3D printing technique that is able to produce small samples of human liver tissue. They claim their new process allows for printing 500 micron thick liver tissue, amounting to 20 cell layers, which is able to produce cholesterol and some of the enzymes produced by the natural liver. The liver samples produced, the company said, can be used by researchers looking to test the efficacy of new drugs designed to treat liver diseases or to test side effects on the liver of drugs created for other purposes.

Currently, companies that develop drugs to treat must rely on 2D tissue samples, which most admit are not optimal. For that reason, many drugs that pass such tests eventually fail trials in live patients. As a result, pharmaceutical companies have been eager to find a better replacement.

The video will load shortly

The process of creating human tissue is one still very much under development. Researchers use various chemicals to coax cells taken from real livers and stem cells to grow tissue that resembles the real thing. Unfortunately, until now, the tissues that result have been just single layers of cells, which flatten when placed in a . And while such tissue does generally produce some of the same enzymes as real livers, allowing researchers to see what impact a drug has, most are not near the level of a real liver—the samples also generally only live for a couple of days. In contrast, the new samples printed by Organovo, the company claims, can live for as long as five days or more.

for the company, Sharon Presnell explained to those at the conference that Organovo's 3D printing process involves printing out two different types of —hepatocytes and stellates—along with the linings of . The result is tissue that the company claims looks, feels and in many ways, behaves just like real human liver tissue. They say it can produce albumin, cholesterol and cytochrome P450s (enzymes that metabolize drugs)—and because of that is much better suited for testing new drugs. She added that the new process marks another step towards the creation of full-size human livers for implanting in people to replace those that have failed, and even went so far as to predict that such technology will come to pass in her lifetime.

The video will load shortly
Organovo's scientific founder, Gabor Forgacs, presents on bioprinting at TEDMED.

Explore further: Mice with human livers make pharmaceutical testing more accurate

More information: Press release

Related Stories

Recommended for you

Anti-tumor antibodies could counter atherosclerosis, study finds

July 20, 2016

Investigators at the Stanford University School of Medicine have learned the signal that tumor cells display on their surfaces to protect themselves from being devoured by the immune system also plays a role in enabling atherosclerosis, ...

A more powerful way to develop therapeutics?

July 21, 2016

A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics', a powerful class of medications that has revolutionized treatment of diseases like rheumatoid ...

Technique uses 3-D weaving to grow a living hip replacement

July 18, 2016

With a goal of treating worn, arthritic hips without extensive surgery to replace them, scientists have programmed stem cells to grow new cartilage on a 3-D template shaped like the ball of a hip joint. What's more, using ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.